Investors


Investors


Juneau Biosciences is a privately held medical genetics company conducting groundbreaking research to develop innovative diagnostic products for diseases that predominantly affect women. Launched in early 2007, the Salt Lake City, Utah-based firm has focused so far on the development of novel molecular diagnostics and therapeutics for endometriosis, a condition estimated to affect approximately 10% of reproductive-age females. This research is the basis for all the tests and therapies that we will produce, patent, and disseminate to signal the revolution in women’s health care.
Juneau Biosciences’ knowledgeable team, state-of-the-art facilities, and innovative research techniques give us a unique advantage in developing diagnostics and treatments for women. We plan to form strategic alliances with health care partners that will complement our technologies and capabilities to commercialize these novel discoveries.

For information regarding investment or partnership opportunities, please contact:

Kenneth Ward

kward@juneaubiosciences.com